Americans Paid $11 Billion To Make Drugs You Can’t Afford
A bombshell report reveals that taxpayers spent billions developing medicines that drugmakers say shouldn’t face Medicare price negotiations.
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
A bombshell report reveals that taxpayers spent billions developing medicines that drugmakers say shouldn’t face Medicare price negotiations.
The government is finally attempting to regulate overpriced drugs, but venture capital firms don’t want to lose their lucrative hold on life-saving pharmaceuticals.
Plus, funding arrives for cleaner energy technologies, insurers’ care-denial bots are put on notice, and regulators tackle an airborne killer.
Plus, more states make Big Oil pay for climate change, new consumer protection rules block junk fees, and the EPA strengthens regulations for forever chemicals.
There’s a basic conflict of interest at the heart of American health care. We need to break up the industry to fix it.
Plus, cancer vaccines work, states aim to tax the rich, and a fossil fuel project gets delayed.
Many health insurers’ online provider directories are inaccurate or out-of-date, to the detriment of patients and health care professionals alike.
Plus, Google suffers a big antitrust defeat, New York’s private colleges could lose wasteful tax breaks, and Massachusetts says goodbye to natural gas.
The Lever breaks down how the country’s largest health insurer uses artificial intelligence to deny rehabilitation services for older and disabled Americans.
Powerful companies are removing hundreds of medicines from insurance plans — and they’re spending millions to stop attempts at reform.